FROP: The Impact of Opioids in Fractures - a Case Control Study
Study Details
Study Description
Brief Summary
In this study, the risk of opioid medications on fractures in older adults is investigated. Patients from the surgical department with fractures and control patients from the internal department of the same hospital are inquired with a standardized questionaire about demographic and clinical risk factors for fractures. Osteoporotic fracture risk is assessed using quantitative ultrasound. An impact of recent opioid medications on fractures is hypothesised.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Patients with fracture fracture within the last 14 days no other fractures within the last 6 month patients >60 years |
|
Control Patients patients hospitalized for an internal reason no other fractures within the last 6 month patients >60 years |
Outcome Measures
Primary Outcome Measures
- Reported Opioid medication before hospital admission [interview: 20 min]
Standardized assessment of opioid medications taken before fracture or hospital admission to evaluate the impact of opioids in fractures. Exact doses, substances and intake habits are inquired.
Secondary Outcome Measures
- Bone density measures using Quantitative ultrasound (SAHARA) [10 min]
Evaluation of fracture risk due to reduced bone density is performed using quantitative ultrasound.
Eligibility Criteria
Criteria
Inclusion Criteria for both groups:
-
age > 60 years
-
written informed consent
Exclusion Criteria for both groups:
-
malignant Disease within the last 12 month
-
troubles with memory, dementia or Parkinsons disease
-
other fractures within the last 6 month
Exclusion Criteria for the fracture group:
-
alcoholised during the fall
-
fracture older than 14 days
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | BG University Hospital Bergmannsheil, Ruhr University Bochum | Bochum | Germany | 44789 |
Sponsors and Collaborators
- Ruhr University of Bochum
- Mundipharma Research GmbH & Co KG
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- FROP_BHL_Bochum